Upcoming Ex-Dividend Dates: On 8/29/25, Ashland Inc (ASH), DuPont (DD), and Dow Inc (DOW) will trade ex-dividend for their upcoming dividends, with payment dates set for 9/12/25 and 9/15/25.
Dividend Amounts: Ashland Inc will pay $0.415, DuPont $0.41, and Dow Inc $0.35 per share in dividends.
Expected Stock Price Adjustments: Following the ex-dividend date, shares of Ashland Inc are expected to drop by 0.74%, DuPont by 0.53%, and Dow Inc by 1.41%.
Historical Dividend Stability: The article emphasizes the importance of reviewing historical dividend payments to gauge future stability, with estimated annual yields of 2.96% for Ashland, 2.12% for DuPont, and 5.65% for Dow Inc.
ASH
$59.83+Infinity%1D
Analyst Views on ASH
Wall Street analysts forecast ASH stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASH is 58.33 USD with a low forecast of 51.00 USD and a high forecast of 65.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Analyst Rating
Wall Street analysts forecast ASH stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASH is 58.33 USD with a low forecast of 51.00 USD and a high forecast of 65.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
4 Hold
0 Sell
Moderate Buy
Current: 59.150
Low
51.00
Averages
58.33
High
65.00
Current: 59.150
Low
51.00
Averages
58.33
High
65.00
BMO Capital
Market Perform -> Outperform
upgrade
$61 -> $71
2025-12-15
New
Reason
BMO Capital
Price Target
$61 -> $71
2025-12-15
New
upgrade
Market Perform -> Outperform
Reason
BMO Capital upgraded Ashland to Outperform from Market Perform with a price target of $71, up from $61. Ashland has "largely cleaned up its portfolio" and is firmly focused on improving costs while continuing to drive its innovation pillars for longer-term growth, says the analyst. With a potential activist in the stock, the firm believes management's focus on execution and value creation will result in an improved risk/reward, the analyst added.
Mizuho
NULL -> Outperform
maintain
$54 -> $60
2025-11-17
Reason
Mizuho
Price Target
$54 -> $60
2025-11-17
maintain
NULL -> Outperform
Reason
Mizuho raised the firm's price target on Ashland to $60 from $54 and keeps an Outperform rating on the shares.
Evercore ISI
In Line
downgrade
$62 -> $53
2025-11-11
Reason
Evercore ISI
Price Target
$62 -> $53
2025-11-11
downgrade
In Line
Reason
Evercore ISI lowered the firm's price target on Ashland to $53 from $62 and keeps an In Line rating on the shares. Q3 marked a shift from earnings-driven moves among chemicals companies, with two-thirds of about 20 chemical names rallying 6% on average post-results, despite half guiding below expectations for Q4 and negative revisions averaging 12%, the analyst tells investors in an earnings recap note for the group.
Wells Fargo
Michael Sison
Equal Weight
downgrade
$53 -> $52
2025-10-15
Reason
Wells Fargo
Michael Sison
Price Target
$53 -> $52
2025-10-15
downgrade
Equal Weight
Reason
Wells Fargo analyst Michael Sison lowered the firm's price target on Ashland to $52 from $53 and keeps an Equal Weight rating on the shares. While chemical earnings will likely sit at trough-like levels through the first half of 2026 or until Fed rate cuts spark a recovery in housing and industrial demand, the firm continues to favor higher quality names trading near commodity multiples.
About ASH
Ashland Inc. is a global additives and specialty ingredients company. The Company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceuticals. The Company’s segments include Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment consists of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films and fine chemicals. The Personal Care segment includes bio functionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. The Specialty Additives segment consists of rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive and various industrial markets. The Intermediates segment consists of the production of 1,4 butanediol (BDO) and related derivatives, including n-methyl pyrrolidone.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
